Wani Shaqul Qamar, Khan Talib, Teeli Ashraf M, Khan Nazir A, Wani Saiful Yamin
Department of Radiation Oncology, Government Medical College and Associated Hospitals, Karan Nagar, Srinagar, India.
J Cancer Res Ther. 2012 Apr-Jun;8(2):272-6. doi: 10.4103/0973-1482.98986.
The aim was to assess the health-related quality of life (HRQOL) and its temporal variation at first visit and subsequent visits among breast cancer patients.
The prospective study was carried out in Outpatient Department of Radiation Oncology, University Teaching and Tertiary Referral Hospital.
After clearance from the ethical committee and EORTC group, 81 surgically treated female breast cancer patients referred to the Outpatient Department of Radiation Oncology for chemoradiation and hormonal therapy were included in the study after informed written consent, irrespective of the age and stage of disease. The patients were interviewed as per the EORTC QLQ-C30 Questionnaire module at four levels at the first visit and at subsequent follow-up visits at 6, 12, and 24 months, respectively, and are still on follow-up.
The data collected were expressed as mean/raw score (RS), standard deviation (SD), and percent mean/scale score expressed on the linear transformation scale, derived as per the calculations and equations of the EORTC QLQ-C30 Scoring Manual. Intragroup comparison (IGC) was done at four levels/visits, a, b, c and d. A P-value of <0.05 was considered significant.
The mean age at presentation was 46.6 ± 10.2 years. The study showed that the physical functioning, role functioning, cognitive functioning, emotional functioning, social functioning, global health status, and symptomatology showed statistically significant improvement over time (P < 0.001).
The survivors of female breast cancer over the long-term follow-up showed significant improvement and coping mechanisms involved in a majority of HRQOL parameters.
评估乳腺癌患者首次就诊及后续就诊时与健康相关的生活质量(HRQOL)及其随时间的变化。
本前瞻性研究在大学教学及三级转诊医院放射肿瘤门诊进行。
经伦理委员会和欧洲癌症研究与治疗组织(EORTC)小组批准后,81例接受手术治疗的女性乳腺癌患者在签署知情书面同意书后被纳入研究,这些患者因放化疗及激素治疗转诊至放射肿瘤门诊,不论疾病的年龄和分期。患者在首次就诊时以及随后分别在6个月、12个月和24个月的随访就诊时,按照EORTC QLQ-C30问卷模块进行四级访谈,目前仍在随访中。
收集的数据以均值/原始分数(RS)、标准差(SD)以及在线性转换量表上表示的均值百分比/量表分数呈现,这些数据是根据EORTC QLQ-C30评分手册的计算和公式得出的。在a、b、c和d四个水平/就诊时间进行组内比较(IGC)。P值<0.05被认为具有统计学意义。
就诊时的平均年龄为46.6±10.2岁。研究表明,随着时间推移,身体功能、角色功能、认知功能、情绪功能、社会功能、总体健康状况和症状学均有统计学意义上的显著改善(P<0.001)。
在长期随访中,女性乳腺癌幸存者在大多数HRQOL参数方面显示出显著改善及应对机制。